Synopsys (NASDAQ:SNPS – Get Free Report) had its price target reduced by equities researchers at Rosenblatt Securities from $560.00 to $530.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the semiconductor company’s stock. Rosenblatt Securities’ price objective points to a potential upside of 18.00% from the stock’s current price.
A number of other equities research analysts also recently commented on the company. Piper Sandler dropped their price objective on Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a report on Thursday. KeyCorp boosted their target price on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Morgan Stanley reissued an “overweight” rating on shares of Synopsys in a research note on Wednesday. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of Synopsys in a research note on Thursday. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $539.00.
Read Our Latest Stock Analysis on Synopsys
Synopsys Stock Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. During the same quarter in the previous year, the company earned $3.03 EPS. Synopsys’s revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities analysts predict that Synopsys will post 10.64 earnings per share for the current year.
Insider Transactions at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 4,157 shares of company stock valued at $1,945,036. Corporate insiders own 0.62% of the company’s stock.
Hedge Funds Weigh In On Synopsys
Hedge funds have recently made changes to their positions in the business. Nolet Wealth Management LLC acquired a new stake in shares of Synopsys in the fourth quarter valued at approximately $228,000. Phillip James Consulting Co. bought a new position in Synopsys in the fourth quarter valued at $36,000. MV Capital Management Inc. acquired a new stake in Synopsys in the 4th quarter valued at $73,000. Sunbelt Securities Inc. increased its stake in Synopsys by 1,250.0% in the 4th quarter. Sunbelt Securities Inc. now owns 243 shares of the semiconductor company’s stock valued at $114,000 after buying an additional 225 shares during the last quarter. Finally, Cambient Family Office LLC bought a new stake in Synopsys during the 4th quarter worth about $3,294,000. 85.47% of the stock is owned by institutional investors.
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Q1 results beat consensus — revenue jumped ~65.6% YoY to $2.409B and non?GAAP EPS of $3.77 topped estimates; company reiterates full?year revenue midpoint and provided robust FY and Q2 EPS ranges. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
- Positive Sentiment: Board authorized a replenishment of the repurchase program (up to $2.0B), supporting shareholder returns and offsetting some integration anxieties. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
- Positive Sentiment: Some analysts remain constructive — Morgan Stanley maintained a Buy and analysts call out solid earnings quality and IP trajectory as catalysts. Synopsys: Strong Earnings Quality … Support Buy Rating
- Neutral Sentiment: Notable option activity — unusually large call buying suggests elevated speculative interest/positioning into or after the print (could magnify intraday moves).
- Negative Sentiment: Guidance and China exposure concerns: Reuters reports Synopsys flagged a more muted near?term outlook tied to China export restrictions and macro uncertainty, which pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
- Negative Sentiment: Debt & integration risk from the large acquisition remains in focus — coverage highlights ~$13.5B in debt and questions about digesting the multibillion acquisition, keeping some investors cautious. Synopsys Carries $13.5 Billion in Debt Into Its Most Consequential Earnings Yet
- Negative Sentiment: Market reaction: several reports note SNPS “slid” despite the beat — investors appear to be weighing forward risks (China, deal debt/integration) more heavily than the quarter’s upside. Synopsys slides despite Q1 results demonstrating 65% revenue surge
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- REVEALED: Something Big Happening Behind White House Doors
- Why the Smart Money Is Looking Beyond Single-Metal Stories
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Read this or regret it forever
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
